Delivery Order SPE2DB24D1205-SPE2DB25FCRVU

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer 750 mg/15 ml vials. The $10,756 firm fixed-price contract has a completion date of February 20, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,228.80 firm fixed price contract is for the provision of Injectafer 750 mg/15 ml vials, with a period of performance through November 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Injectafer 750 mg/15 ml vials. The contract is a Delivery Order with a Firm Fixed Price of $26,309.19 and a period of performance through February 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.41 firm-fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials, with a period of performance through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Injectafer 750 mg/15 ml vial (15 ml) to the Defense Logistics Agency. The $22,558.15 firm fixed-price delivery order has a completion date of June 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,003.58 firm fixed-price delivery order is for the supply of Injectafer, a 750 mg/15 ml vial medication, with an ultimate completion date of October 11, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Injectafer 750 mg/15 ml vials. The contract has a firm fixed price of $3,217.98 and a period of performance through September 18, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which provides a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation. The contract, valued at $34,643.76, is for the delivery of Injectafer 750 mg/15 mL vials. It is a firm fixed-price delivery order contract with an ultimate completion date of August 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,398.11 firm fixed-price delivery order is for the supply of Injectafer 750 mg/15 ml vials, a specialty medication. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 30, 2024. The contract is not designated as a set-aside. It is part of a larger $999,999,999 Indefinite...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,850.63, is for the delivery of Injectafer 750 mg/15 ml vials. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCRVU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer, a 750 mg/15 mL injectable medication. The $2,414.43 firm fixed-price delivery order has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award is part of AmerisourceBergen's broader portfolio of federal contract vehicles, including a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/21/25, 9:52 AM